Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXE6DZ
|
||||
| Drug Name |
N-Cyanomethyl-2-diphenylacetylamino-3-phenyl-propionamide
|
||||
| Synonyms |
CHEMBL342145
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H23N3O2
|
||||
| Canonical SMILES |
O=C(NCC#N)[C@H](Cc1ccccc1)NC(=O)C(c2ccccc2)c3ccccc3
|
||||
| InChI |
InChI=1S/C25H23N3O2/c26-16-17-27-24(29)22(18-19-10-4-1-5-11-19)28-25(30)23(20-12-6-2-7-13-20)21-14-8-3-9-15-21/h1-15,22-23H,17-18H2,(H,27,29)(H,28,30)/t22-/m0/s1
|
||||
| InChIKey |
RAWKSIKXMYXSHO-QFIPXVFZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.